Problems in setting up the first trial of an HIV-1 vaccine in Uganda are described here by Mugerwa and colleagues. The authors explain how they solved these problems and give suggestions to help researchers who are starting future trials of HIV vaccines.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Jan 26 2002|
ASJC Scopus subject areas